Hui Wang
Impact in
- Biological Psychiatry top 1%
- Biomaterials top 1%
- Nanoparticle-Based Drug Delivery
Papers in
-
- Chemical Synthesis and Analysis 18
- Co-authors
- Zibo Li (51 shared papers)Mengzhe Wang (32 shared papers)Bo Tang (18 shared papers)Ping Li (15 shared papers)Depu Chen (3 shared papers)Chenghui Liu (3 shared papers)Zhanhong Wu (27 shared papers)Kai Chen (10 shared papers)
- Journals
- Chemical Communications (10 papers)Frontiers in Oncology (8 papers)Journal of Clinical Oncology (6 papers)European Journal of Nuclear Medicine and Molecular Imaging (6 papers)Molecular Pharmaceutics (6 papers)
- Partner nations
- ChinaUnited StatesFrance
In The Last Decade
Hui Wang
468 papers receiving 12.6k citations
Hui Wang's Hit Papers
Peers
Comparison fields: 5 of 176
- Biological Psychiatry 321
- Biomaterials 840
- Molecular Biology 4.0k
- Cancer Research 786
- Biomedical Engineering 2.5k
Countries citing papers authored by Hui Wang
This map shows the geographic impact of Hui Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hui Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hui Wang more than expected).
Fields of papers citing papers by Hui Wang
This network shows the impact of papers produced by Hui Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hui Wang. The network helps show where Hui Wang may publish in the future.
Co-authors
The 25 scholars most cited alongside Hui Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 509 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 305 | |
| 2 | 2016 | 238 | |
| 3 | 2009 | 219 | |
| 4 | 2016 | 204 | |
| 5 | 2004 | 195 | |
| 6 | 2016 | 189 | |
| 7 | 2009 | 188 | |
| 8 | 2018 | 178 | |
| 9 | 2008 | 175 | |
| 10 | 2002 | 164 | |
| 11 | 2011 | 163 | |
| 12 | 2019 | 158 | |
| 13 | 2008 | 157 | |
| 14 | 2009 | 156 | |
| 15 | 2012 | 155 | |
| 16 | 2008 | 154 | |
| 17 | Tumor necrosis factor is a brain damaging cytokine in cerebral ischemia. | 1997 | 146 |
| 18 | 2012 | 143 | |
| 19 | Intratracheal administration of polystyrene microplastics induces pulmonary fibrosis by activating oxidative stress and Wnt/β-catenin signaling pathway in mice Hit paper breakdown → | 2022 | 141 |
| 20 | 2016 | 139 |
About Hui Wang
Hui Wang is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine, Radiology, Nuclear Medicine and Imaging, Materials Chemistry and Biomedical Engineering, having authored 509 papers that have together received 12.8k indexed citations. Recurring topics across this work include Nanoplatforms for cancer theranostics (37 papers), Luminescence Properties of Advanced Materials (28 papers), Monoclonal and Polyclonal Antibodies Research (25 papers), Luminescence and Fluorescent Materials (23 papers), Radiopharmaceutical Chemistry and Applications (21 papers), Click Chemistry and Applications (20 papers), Medical Imaging Techniques and Applications (20 papers) and Chemical Synthesis and Analysis (18 papers). The work is most often cited by research in Biological Psychiatry (321 citations), Biomaterials (840 citations), Molecular Biology (4.0k citations), Cancer Research (786 citations) and Biomedical Engineering (2.5k citations). Hui Wang has collaborated with scholars based in China, United States and France. Frequent co-authors include Zibo Li, Mengzhe Wang, Bo Tang, Ping Li, Depu Chen, Chenghui Liu, Zhanhong Wu, Kai Chen, Weibo Cai and Wen Zhang. Their work appears in journals such as Chemical Communications, Frontiers in Oncology, Journal of Clinical Oncology, European Journal of Nuclear Medicine and Molecular Imaging and Molecular Pharmaceutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.